| Specialty
Groups Oncology
American College of
Surgeons Commission on Cancer (ACOS-CoC) Liaison Report
The American College
of Surgeons Commission on Cancer held their annual committee meeting in
June of 2005 at which time members of the Approvals Committee addressed
a number of issues with the 2004 Standards and approved modifications to
them. A revised edition of the Cancer Program Standards 2004
will be available December of 2005. In brief, the issues addressed and
their outcomes are as followed:
Standard 2.3 required programs to have a Cancer
Liaison Physician (CLP) as coordinator of community outreach. This role
has been revised and the role given more flexibility. The solutions are
to allow facility-based staff appointed as the Community Outreach
Coordinator, the CLP appointed as the Community Outreach facilitator who
works in concert with facility-based community outreach staff or the CLP
appointed to another designated Coordinator role. These solutions will
be effective January 1, 2006 for surveys performed in 2006.
Standards
3. 4 and 3.
5 address percentage follow-up rates maintained for all analytic patients
from the cancer registry reference date and all patients diagnosed within
the last five years, or from the cancer registry reference date, whichever
is shorter. The solution to the issues associated with these 2 standards
eliminates the requirement to perform follow-up on patients classified as
Class of Case O diagnosed on or after January 1, 2006.
Standard 4.2 required
cancer programs to have an inpatient medical oncology unit or a functional
equivalent to provide specialized care to patients. The solution to the
issues surrounding this standard has been implemented immediately for those
programs designated as Teaching Hospital Cancer Programs (THCP). THCPs will
document a process to refer patients needing hospitalization for specialized
medical oncology services to a facility with a designated inpatient medical
oncology unit or document that a functional equivalent medical oncology unit
is in place at the THCP. A functional equivalent is defined as the
provision of specialized medical oncology care regardless of the location of
the inpatient bed. Programs surveyed during 2004 and 2005 that received a
deficiency for standard 4.2 will have the opportunity to show documentation
of either of the above approved options and have their deficiency removed.
Standard 4. 3
addresses AJCC staging being assigned by the managing physician and recorded
on a staging form in the medical record on 90 percent of eligible annual
analytic cases. The solutions to the issues surrounding this standard
include adding the flexibility of allowing Advanced Nurse Practitioners and
Specialized Physician Assistants to assign staging, and record and sign
staging in the medical record with a managing physician co-signature after
January 1, 2006. Also, the revisions would eliminate the AJCC staging
requirement for patients diagnosed on or after January 1, 2006 that are
classified as Class of Case O.
For more detail on
these revisions, the issues provoking the changes and previous standard
revisions log on to www.facs.org/cancer
.
The ACoS-CoC Report was prepared by ACOA/ACoS-CoC liaison, Jeannie O’Leary.
Her role as liaison is to enhance our relationship and collaboration by
providing a forum for the exchange of ideas, initiatives, critical issues,
and actions that impact cancer care, data collection, and research. We have
the opportunity to bring matters of importance for ACOA to the CoC, as well
as communicate CoC activities to the ACOA. If you have input on particular
issues regarding credentialing and ACoS standards, please contact
Jeannie O’Leary.
|